Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Avis Budget Group, Inc. regarding a class action lawsuit due to allegations of materially false and misleading statements made by the company during the specified class period [1]. Group 1: Allegations - The complaint alleges that Avis Budget implemented a plan to significantly accelerate its fleet rotation in Q4 2024 [1]. - This acceleration reportedly shortened the useful life of most vehicles in the Americas segment, reducing their recoverable value [1]. - As a result, Avis Budget is expected to recognize billions of dollars in impairment charges and incur substantial losses [1]. - The allegations suggest that these actions had a significant negative impact on the company's financial results and overstated its business prospects [1]. Group 2: Class Action Details - The class period for the lawsuit is from February 16, 2024, to February 10, 2025 [1]. - Shareholders are encouraged to register for the class action by June 24, 2025, to potentially be appointed as lead plaintiffs [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies adhere to responsible business practices and engage in good corporate citizenship [3].

Core Viewpoint - Avis Budget Group, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 16, 2024, and February 10, 2025 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Avis Budget implemented a plan to significantly accelerate its fleet rotation in Q4 2024, which shortened the useful life of most vehicles in the Americas segment [2] - This acceleration is alleged to have led to billions of dollars in impairment charges and substantial losses for the company [2] - The financial and business prospects of Avis Budget were reportedly overstated, resulting in materially false and misleading public statements by the defendants [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until June 24, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Group 1 - The Rosen Law Firm is reminding investors who purchased Avis Budget Group, Inc. securities between February 16, 2024, and February 10, 2025, of the June 24, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court by June 24, 2025, to serve as lead plaintiff [3] Group 2 - The lawsuit alleges that during the Class Period, Avis Budget made false and misleading statements regarding its fleet rotation plan, which negatively impacted the recoverable value of its vehicles [5] - The lawsuit claims that Avis Budget would have to recognize billions of dollars in impairment charges and incur substantial losses due to the accelerated fleet rotation [5] - The misleading public statements by Avis Budget are said to have overstated the company's financial and business prospects, leading to investor damages when the truth was revealed [5] Group 3 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4]

Core Viewpoint - Avis Budget Group, Inc. is facing a class action lawsuit due to significant financial losses reported for Q4 2024, attributed to a strategic shift in fleet rotations that led to substantial impairment charges and misleading statements made to investors [2][3]. Financial Performance - For Q4 2024, Avis reported a loss of $1.96 billion, equating to $55.66 per share, a stark contrast to a profit of $259 million, or $7.10 per share, in the same quarter of the previous year [2]. - The financial loss was primarily due to a one-time non-cash impairment of $2.3 billion and additional non-cash charges of $180 million resulting from the accelerated fleet rotation strategy [2]. Strategic Changes - The company implemented a plan to significantly accelerate fleet rotations, which shortened the useful life of most vehicles in the Americas segment, thereby reducing their recoverable value [3]. - The transition of the CEO to a Board Advisor role was also announced, indicating potential leadership changes within the company [2]. Legal Proceedings - A class action lawsuit has been filed on behalf of investors who acquired Avis securities between February 16, 2024, and February 10, 2025, with a deadline of June 24, 2025, to file a lead plaintiff motion [1][4]. - The lawsuit alleges that the company made materially false and misleading statements regarding its business operations and financial prospects during the class period [3].

Core Viewpoint - Avis Budget Group, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 16, 2024, and February 10, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Avis Budget implemented a plan to significantly accelerate its fleet rotation in Q4 2024, which shortened the useful life of most vehicles in the Americas segment [2]. - This acceleration is alleged to have reduced the recoverable value of the vehicles, leading to billions of dollars in impairment charges and substantial losses for the company [2]. - As a result, the financial and business prospects of Avis Budget were overstated, making the defendants' public statements materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until June 24, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, highlighting its expertise in complex securities litigation [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Avis Budget Group, Inc. regarding a class action lawsuit due to allegations of materially false and misleading statements made by the company during the class period from February 16, 2024, to February 10, 2025 [1]. Allegations - The complaint alleges that Avis Budget implemented a plan to significantly accelerate its fleet rotation in Q4 2024, which shortened the useful life of most vehicles in the Americas segment, reducing their recoverable value [1]. - As a result of the accelerated fleet rotation, Avis Budget is expected to recognize billions of dollars in impairment charges and incur substantial losses [1]. - The allegations suggest that these actions had a significant negative impact on the company's financial results and overstated its financial and business prospects [1]. Class Action Details - Shareholders who purchased shares of CAR during the specified class period are encouraged to register for the class action, with a deadline of June 24, 2025, to seek lead plaintiff status [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avis Budget Group, Inc. due to allegations of violations of federal securities laws related to misleading statements and significant financial losses [2][4]. Group 1: Legal Investigation and Class Action - The firm is reminding investors of the June 24, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against Avis [2]. - Investors who suffered losses in Avis between February 16, 2024, and February 10, 2025, are encouraged to contact the firm to discuss their legal rights [1][2]. Group 2: Financial Performance and Impairment Charges - Avis Budget reported a loss of $1.96 billion, or $55.66 per share, for the fourth quarter of 2024, compared to a profit of $259 million, or $7.10 per share, for the same period in the prior year [5]. - The loss was attributed to a strategic change that significantly accelerated fleet rotations, resulting in a one-time non-cash impairment of $2.3 billion and additional non-cash charges of $180 million [5]. Group 3: Management Changes - Following the financial results announcement, CEO Joseph A. Ferraro will transition to a Board Advisor role effective June 30, 2025, with Brian Choi taking over as CEO on July 1, 2025 [6]. - The stock price of Avis Budget fell by $6.12 per share, or 6.82%, closing at $83.59 per share on February 11, 2025, after the announcement [6]. Group 4: Allegations of Misleading Statements - The complaint alleges that Avis Budget and its executives made false and misleading statements regarding the company's fleet rotation strategy and its impact on financial results [4]. - It is claimed that the acceleration of fleet rotation shortened the useful life of vehicles, leading to billions in impairment charges and negatively affecting the company's financial outlook [4].

Core Insights - Broad Arrow Auctions, a subsidiary of Hagerty, is launching a new auction event called the Zoute Concours Auction in collaboration with Zoute Grand Prix Car Week, scheduled for October 10, 2025, in Belgium [1][2][3] - The auction will feature approximately 70 exceptional collector cars, showcasing a variety of categories and price points, enhancing Broad Arrow's presence in the European market [1][2][3] Company Overview - Broad Arrow Auctions was founded in 2021 and has quickly become a leading global collector car auction house, known for its high-quality offerings and rapid growth in the auction segment [5] - The company recently debuted in Europe as the official auction partner for BMW AG at the Concorso d'Eleganza Villa d'Este, achieving €31.2 million in sales with 78% of lots sold [3][5] Event Details - The Zoute Grand Prix Car Week is a prestigious five-day festival that combines exceptional automobiles, art, and luxury lifestyle, attracting collectors and enthusiasts from around the world [2][7] - The Zoute Concours Auction will coincide with the Zoute Concours d'Élégance, further elevating the event's profile and providing a platform for showcasing automotive elegance [2][3][7] Strategic Partnerships - The partnership between Broad Arrow and Zoute Grand Prix aims to enhance the international character of the event and expand both companies' global reach [3][7] - This collaboration is seen as a natural fit, driven by a shared vision of excellence and ambition [3]

Core Insights - CARsgen Therapeutics has announced positive results from the pivotal Phase II clinical trial of satricabtagene autoleucel ("satri-cel") for treating Claudin18.2-positive advanced gastric/gastroesophageal junction cancer, which were published in The Lancet and presented at the 2025 ASCO Annual Meeting [1][2][3] Company Overview - CARsgen Therapeutics is focused on developing innovative CAR T-cell therapies to address unmet clinical needs in hematologic malignancies, solid tumors, and autoimmune diseases [7] - The company has established comprehensive capabilities for CAR T-cell research and development, including target discovery, preclinical research, clinical development, and commercial-scale production [7] Clinical Trial Details - The CT041-ST-01 trial is the first randomized controlled clinical study of CAR-T cell therapy for solid tumors, demonstrating significant clinical benefits such as improved progression-free survival (PFS), overall survival (OS), and tumor response rates in heavily pretreated patients [4] - The trial results indicate that satri-cel offers breakthrough efficacy for patients with limited treatment options and poor prognosis [4] Regulatory Designations - Satri-cel has received Breakthrough Therapy Designation and Priority Review from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for treating Claudin18.2-positive advanced gastric/gastroesophageal junction adenocarcinoma [6] - The company plans to submit a New Drug Application (NDA) for satri-cel to the NMPA, anticipating it to be the first commercially available CAR-T product for solid tumors [4][6] Future Development Plans - CARsgen is exploring satri-cel's potential in adjuvant settings and as first-line sequential therapies to intervene earlier in the disease course and extend patient survival [4] - Ongoing trials include various phases for treating advanced gastric/gastroesophageal junction adenocarcinoma and pancreatic cancer [5]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avis Budget Group, Inc. due to allegations of false and misleading statements related to significant financial losses and impairment charges resulting from a strategic change in fleet rotation [2][4]. Group 1: Legal Investigation and Class Action - The law firm is encouraging investors who suffered losses in Avis between February 16, 2024, and February 10, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Avis, with a deadline of June 24, 2025, for investors to seek the role of lead plaintiff [2][6]. - The lead plaintiff is defined as the investor with the largest financial interest who directs the litigation on behalf of the class [6]. Group 2: Financial Results and Impact - Avis Budget reported a loss of $1.96 billion, or $55.66 per share, for the fourth quarter of 2024, a significant decline from a profit of $259 million, or $7.10 per share, in the same period the previous year [5]. - The loss was attributed to a strategic decision to accelerate fleet rotations, leading to a one-time non-cash impairment of $2.3 billion and additional non-cash charges of $180 million [5]. - Following the announcement of these results, Avis Budget's stock price fell by $6.12 per share, or 6.82%, closing at $83.59 per share on February 11, 2025 [5]. Group 3: Management Changes - The CEO of Avis Budget, Joseph A. Ferraro, will transition to a Board Advisor role effective June 30, 2025, with Brian Choi taking over as CEO on July 1, 2025 [5].